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Abstract l Background: The study
was carried out to evaluate the cor-
relation between blood-retinal barrier
(BRB) permeability and the progres-
sion of diabetic retinopathy (DR),
defined by development of “need for
photocoagulation”, over a 7-year pe-
riod by means of vitreous fluorome-
try (VF). l Methods: Forty type 2
diabetic patients with minimal or no
retinopathy, aged 40–65 years (mean
53.9 + 7.3 years), were followed up
prospectively for 7 years. Investiga-
tions including standard ophthalmo-
logical examination, fundus photog-
raphy, fluorescein angiography and
VF were performed at entry and 1, 4,
5 and 7 years later. Only one eye per
patient was included in the study.
Need for photocoagulation was based
on Early Treatment Diabetic Reti-
nopathy Study protocols and decided
by the attending ophthalmologist.
l Results: After 7 years of follow-up
a total of 22 of the 40 eyes had re-
ceived photocoagulation. The eyes
that needed photocoagulation were
those that had higher VF values at the
entry of the study and showed higher
rates of deterioration (initial values
5.1 + 1.9 vs 2.8 + 1.510–6 min–1,
P<0.001; annual increase in leakage
for the first year, 1.5 + 0.8 vs 0.5 +
1.010–6 min–1 , P<0.001,). The eyes
that did not need photocoagulation
during the 7 years of follow-up
showed stable VF readings (-0.1 +
1.210–6 min– 1, difference between
initial values and 7 years later).
l Conclusions: Abnormally high VF
values and their rapid increase over
time are good indicators of progres-
sion and worsening of the retinopathy
in diabetes type 2.
Introduction
Retinopathy is the most frequent microvascular complica-
tion of diabetes mellitus. At present, the only proven
treatment is photocoagulation, which is performed when
the disease process is already irreversible [4]. Photocoag-
ulation is recommended for two major events associated
with loss of vision and worsening of the retinopathy,
namely growth of new vessels or development of clinical-
ly significant macular edema. The latter, macular edema,
is particularly frequent in diabetes type 2. For prevention
and improved treatment of diabetic retinopathy (DR) it is
fundamental to know the evolution of the earliest changes
that occur in the patient with diabetes and how they are
related to progression of the retinopathy.
One of the earliest changes occurring in the diabetic
retina is an alteration of the blond-retinal barrier. This
is demonstrated well by fluorescein angiography but re-
quires vitreous fluorometry to be quantified in a reproduc-
ible manner.
Using fluorescein angiography and vitreous fluorome-
try, we evaluated prospectively a series of patients with
adult-onset diabetes mellitus with moderate or no retinop-
athy. The patients were examined at entry into the study
and at 1, 4, 5 and 7 years after the initial examination.
A need for photocoagulation, as determined by pre-estab-
lished guidelines, was considered a primary outcome indi-
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cating worsening of the retinopathy. The results of the
first 4 years of follow-up have been published [2]. We
have now extended the follow-up of the patients to a total
of seven 7 years, and the final results are now reported.
Material and Methods
Forty patients with adult-onset diabetes, type 2 (age at diagnosis 30
years or more) with retinopathy no greater than level 3 of the mod-
ified Airlie House classification [3] in the macular area, were fol-
lowed up for the period of the study. Forty-three patients were ini-
tially enrolled but three did not complete the first year of follow-
up. Thereafter there were no more losses to follow-up. Only one
eye per patient was included in the study. All the results reported
here are from the same eye for each patient.
Ophthalmological examination, fundus photography, fluorescein
angiography and vitreous fluorometry were performed on entry into
the study and 1, 4, 5 and 7 years later. Photocoagulation was per-
formed by the attending ophthalmologist whenever it was consid-
ered needed and following Early Treatment Diabetic Retimopathy
Study guidelines [2]. Vitreous fluorometry was performed only in
patients who had not undergone photocoagulation.
The 40 patients covered an age range of 40–65 years (mean 53.9
 7.3 years), and all had had diabetes for more than 4 years at the
start of the study (mean 9.9  4.7 years). The patients were followed
up in the diabetes clinic and remained within the limits of acceptable
good control. The glycemic control at entry was fasting blood glu-
cose 10.89  4.39 mmol/l and HbA (%) 9.97  3.74, (mean 
SD). Approval for the study was obtained from the ethics committee
of Coimbra University Hospital, and all patients gave informed con-
sent prior to enrollment.
Retinopathy grading
After maximal dilation of the pupil, fundus photographs were
taken of both eyes in fields 1 and 2 as defined by the Diabetic Ret-
inopathy Study [3]. A solution of 20% sodium fluorescein (14 mg kg
body weight) was then injected intravenously. The fluorescein angi-
ography was performed according to a set protocol [2]. Microaneu-
rysms were graded semi-quantitatively into four categories: 0, ab-
sent or questionable; 1, one to five microaneurysms; 2, five to ten
microaneurysms; 3, more than ten microaneurysms.
Ocular fluorometry
The measurements were made with a commercial fluorophotometer,
the Fluorotron Master (Ocumetrics, alif: USA). Scans were taken
before the administration of fluorescein and 60 min after injection.
Details of the procedure and determination of the vitreous fluorom-
etry penetration ratio (VFPR), which reflects blood-retinal barrier
permeability, are described in the previous 4-year report of this
study [2]. The normal value of the vitreous VFPR in a series of
22 persons below 60 years is 2.7  0.810–6 min–1 (mean + 2SD,
4.3  10–6 min–1 , upper value of normal range with 95% degree
of confidence) [7].
Evaluation parameters and statistics
The purpose of the study was to compare permeability values and
the long-term clinical course. As parameter for evaluation of the
clinical course, need for photocoagulation was chosen. Data were
analysed using one-way (analyses of variance) ANOVA and the un-
paired Students t-test.
Results
All but three patients enrolled in the study had had known
diabetes for between 5 and 10 years. Only three had had
diabetes for more than 10 years. The microaneurysm
gradings at entry into the study were well distributed
within the four categories: 9 eyes with retinopathy grade
0, 13 with retinopathy grade 1, 7 with retinopathy grade 2
and 11 with retinopathy grade 3 (table 1).
The VFPRs are presented in Table 1. At entry the
mean value was 4.1  2.010–6 min–1. The difference
from normal is statistically significant (P<0.001). Seven-
teen eyes (43%) had a VFPR higher than 4.3  10–6 min–1
(upper value of normal with 95% degree of confidence).
Of the 40 eyes in the study, 16 were photocoagulated
during the period between 1 and 4 years after the initial
examination, another 2 received photocoagulation after
the 4th year and before the 5th year examination, and a
further 4 needed photocoagulation before the 7th year fol-
low-up examination. In total, 22 of the 40 eyes (55%), en-
rolled were photocoagulated during the 7th year follow-
up period.
BRB permeability and development of need
for photocoagulation
Examination of the initial fluorophotometric values shows
that the eyes that progressed to photocoagulation had
clearly higher initial VFPR and more marked alteration
of the BRB than the eyes that did not need photocoagula-
tion (5.1  1.9  10–6 min–1 vs. 2.8  1.5  10–6 min–1;
respectively; P<0.001) (Fig. 1).
Furthermore, the eyes that needed photocoagulation
showed a clear increase in VFPR in the one 1-period of
follow-up immediately before the development of need
for photocoagulation (P<0.001). For the 16 eyes that
were photocoagulated before the 4-year examination,
the increase in VFPR during the first year of follow-up
was 1.5  0.8  10–6min–1 (P<0.0001) and for the four
eyes that were photocoagulated before the 7-year exami-
nation the increase in VFPR during the year between the 4
and 5-years examination was 2.8  1.5  10–6 min–1
(P<0.06). This is in clear contrast (P<0.001) with the dif-
ferences in VFPR values in the same periods for the eyes
that did not need photocoagulation, which remained re-
markably stable (respectively, 0.4  1.0  10–6 min–1
and 0.1  1.2  10-6 min–1).
The 18 eyes that did not need photocoagulation during
the entire 7-year period of follow-up, showed stable
VFPR values (-0.1 + 1.2  10–6 min–1 , P<0.8).
When using for comparison the value of 4.310-6 min–1,
corresponding to the normal mean value plus two stan-
dard deviations, it was observed that of the 22 eyes that
developed need for photocoagulation, 19 had higher
VFPR values in the last vitreous fluorometry examination
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Table 1 Vitreous fluorometry






Baseline One year Four years Five years Seven years
1 11 1 8.27 10.01 Pa – –
2 20 0 4.87 3.00 5.70 2.00 2.32
3 10 0 2.94 2.91 3.38 2.41 2.10
4 6 2 7.72 8.99 P – –
5 8 3 4.01 3.79 P – –
6 5 0 3.40 3.88 2.81 5.00 4.02
7 10 3 11.22 12.60 P – –
8 14 1 2.95 3.70 2.66 2.46 2.12
9 6 0 4.60 5.50 3.38 5.93 P
10 10 3 5.10 7.31 Pa – –
11 14 2 5.22 5.85 5.10 7.36 P
12 10 1 6.32 8.32 4.65 3.67 4.30
13 8 3 4.90 7.07 Pa – –
14 25 2 2.32 2.37 1.24 2.49 2.31
15 10 1 4.56 6.60 P – –
16 22 3 2.35 3.00 2.85 2.84 2.16
17 12 3 5.80 8.04 Pa – –
18 5 2 3.21 2.59 2.24 2.24 1.86
19 7 1 4.63 5.90 P – –
20 12 3 1.86 3.40 4.05 3.05 4.20
21 5 1 1.85 3.90 1.59 2.06 3.00
22 11 0 2.71 4.07 Pa – –
23 7 3 2.07 2.58 1.81 1.30 2.51
24 14 3 3.53 3.71 4.13 2.02 2.99
25 5 0 3.71 3.02 2.91 7.82 P
26 10 0 3.12 4.78 4.87 P –
27 15 1 3.26 5.46 4.26 5.79 P
28 9 3 1.49 2.91 0.70 1.79 0.97
29 9 2 4.93 5.31 P – –
30 5 1 5.92 7.75 P – –
31 4 1 3.74 4.23 3.32 P –
32 5 3 3.97 4.33 3.50 2.57 3.75
33 10 2 1.78 2.37 1.83 1.83 1.38
34 9 1 4.72 6.79 P – –
35 9 1 5.73 8.07 P – –
36 5 1 1.45 1.63 1.80 1.47 2.27
37 15 2 1.91 1.41 2.96 1.37 3.46
38 6 1 4.79 6.15 P – –
39 10 0 3.67 3.79 P – –
40 8 0 2.72 2.24 3.52 2.70 4.15
a Eyes that received both focal and panretinal photocoagulation
Fig. 1 VFPR (10–6 min–1) eva-
luation over the 7-year period
(— j— eyes that did not need
photocoagulation over the
whole period, - - —s - - eyes that
needed photocoagulation be-
tween 1st- and 4th-year exami-
nation, - - —l - - eyes that needed
photocoagulation between 4th-
and 5th-year examination,
—j— eyes that needed photo-
coagulation between 5th- and
7th-year examination)
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before photocoagulation (86%), whereas only three eyes
(14%) presented lower VFPR values in the last examina-
tion before need for photocoagulation was established
(P<0.0001).
Retinopathy grading and need for photocoagulation
Classification of the eyes according to microaneurysm
count showed initially 9 eyes with level 0, 13 at level 1,
7 at level 2 and 11 at level 3. This type of retinopathy
grading did not show any correlation with the develop-
ment of need for photocoagulation (P>0.35), the primary
end-point of the study (table 2).
Discussion
The present prospective study was undertaken to establish
whether there is a correlation between BRB permeability
and the clinical course of retinopathy in type 2 diabetes
mellitus. Need for photocoagulation following pre-estab-
lished guidelines according to the ETDRS protocol is
the best available indicator for progression and worsening
of the retinopathy. Establishment of “need for photocoag-
ulation” is the result of the development in the diabetic
retina of clinically significant macular edema or prolifer-
ative retinopathy and was, therefore, considered the pri-
mary end-point of the study. Only eyes with moderate
or no retinopathy were included. The diabetic patients
in the study had blood pressure within normal limits
and were under acceptable metabolic control.
A first report published after 4 years of follow-up
showed a positive correlation (r2 = 0.11, P=0.02) between
high BRB permeability and development of need for pho-
tocoagulation, even among patients with the same retinal
morphology [2]. A positive correlation was also registered
between fast rates of increase in BRB permeability during
the first year of follow-up and future need for photocoag-
ulation (r2 = 0.13, P=0.001).
By the end of 4 years of follow-up, 16 of the 40 study
eyes had received photocoagulation, of the focal type in
11 and panretinal in 5. These eyes had higher fluorometric
values for BRB permeability at entry into the study and
presented faster deterioration of the BRB during the first.
year of follow-up. Microaneurysm counts remained stable
during the same period, showing that a morphological
classification was less effective than BRB permeability
quantification for recording progression of retinal damage
in short periods of follow-up.
We have now extended the follow-up of the same study
population to a total of 7 years, performing examinations 5
and 7 years after the beginning of the study. The results
obtained confirm previous findings and further strengthen
the observation that high BRB permeability values are
highly correlated with development of need for photoco-
agulation, i.e., progression and worsening of diabetic reti-
nopathy. The 16 eyes that had been photocoagulated at the
4 year examination showed faster rates of increase in BRB
permeability during the first year of follow-up. The same
finding was clearly repeated in the four eyes that needed
photocoagulation before the 7- year follow-up examina-
tion. These eyes had statistically significant faster rates
of increase in BRB permeability during year of follow-
up, between the 4- and 5-year examinations. Compared
with the eyes that never developed need for photocoagula-
tion and in which the vitreous fluorometry values re-
mained remarkably stable, it may be stated that in patients
with diabetes type 2, high fluorometry values and/or a rap-
id increase in vitreous fluorometry values over periods of
1 year are good predictors for progression of the retinop-
athy and development of need for photocoagulation.
Furthermore, in this 7-year follow-up study vitreous
fluorometry values appear to be clearly better predictors
of progression of retinopathy than fluorescein angiogra-
phy grading or duration of the disease.
Microaneurysm counts for grading of the retinopathy
at entry into the study did not show any specific correla-
tion with future development of need for photocoagula-
tion (Table 2).
It is interesting to verify that, although the rate of de-
velopment of need for photocoagulation, particularly in
association with the occurrence of clinically significant
macular edema, is faster in diabetes type 2 than in diabe-
tes type 1 [6], a consideratle proportion of patients (45%)
showed remarkably stable vitreous fluorometry values
during the 7 year period of follow-up. In a few cases
(nos. 12 and 28) there were important decreases in VFRV
values during the course of the follow-up. No clear expla-
nation could be found for this finding, probably due to the
limited member of cases showing such behaviour.
Our study confirms in diabetes type 2 the observations
made by other authors in diabetes type 1 showing, in the
earlier stages of the retinopathy, a correlation between high-
er BRB permeability and retinopathy progression [1, 5].
The present study, using need for photocoagulation as
the primary end-point, suggests that high BRB permeabil-
ity is of clinical significance by virtue of identifying the
eyes at risk for retinopathy progression. The results indi-
cate that eyes of patients with type 2 diabetes who present
higher VFPR and faster rates of deterioration of the BRB
are at risk and should be followed up more closely in or-
der to ensure appropriate treatment and at the best time.
New forms of prevention and treatment of diabetic reti-
nopathy should be tested primarily in this group of eyes.







0 9 4 5 (= 55 %)
1 13 4 9 (= 69 %)
2 7 4 3 (= 43 %)
3 11 6 5 (= 45 %)
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